To validate our TCGA expression profiling and our recent findings that CCM2 expression is frequently perturbed in breast tumors [6, 10], we further investigated additional breast cancer tissue pairs using different panels with larger sample sizes. This evidence concerns the gene CCM2 and breast carcinoma.